Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?

J Pathol. 1999 Dec;189(4):527-32. doi: 10.1002/(SICI)1096-9896(199912)189:4<527::AID-PATH488>3.0.CO;2-N.

Abstract

A recent study observed that numerical chromosome abnormalities in Hodgkin's disease (HD) are detected not only in morphologically abnormal Hodgkin/Reed-Sternberg cells, but also in a fraction of morphologically normal cells. However, the phenotypic constitution of these genetically abnormal, morphologically normal cells and their relationship to the malignant Hodgkin/Reed-Sternberg cells could not be established in the earlier cases studied, because of the low frequency of these cells. The present study investigated two cases of classical Hodgkin's disease containing a relatively large population of such apparently normal cells with aberrant chromosome copy numbers. The phenotype and their position within the developmental route of the malignant compartment were examined by a combined in situ hybridization and immunocytochemistry approach. Numerical abnormalities for chromosome 1 in one case and for chromosomes X, Y, and 1 in the other case were observed not only in CD30-positive Hodgkin/Reed-Sternberg cells, but also in CD30-negative, morphologically normal cells. It was shown that these genetically aberrant cells expressed the B-cell antigen CD19, thus confirming their B-cell nature. These studies indicate a relationship between the genome aberrations in these genetically abnormal, morphologically normal B-cells and the Hodgkin/Reed-Sternberg cells, suggesting that they are progenitor cells of the malignant cell fraction.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology*
  • Chromosome Aberrations*
  • Genotype
  • Hodgkin Disease / genetics*
  • Hodgkin Disease / immunology
  • Hodgkin Disease / pathology
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Ki-1 Antigen*
  • Male
  • Neoplastic Stem Cells / immunology
  • Neoplastic Stem Cells / pathology*
  • Phenotype
  • Reed-Sternberg Cells / immunology
  • Reed-Sternberg Cells / pathology*

Substances

  • Ki-1 Antigen